← Back

Wire · regulatory

DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI ...

Published

13 August 2026

Topic

regulatory

◆ Sectors

Digital Health

◆ Geography

Saudi Arabia

◆ Source

Read at investingnews.com →

◆ Verified

Fusion42 · 13 August 2026 · Fusion42 review

Diagnos Inc. received Medical Device Marketing Authorization from the Saudi Food and Drug Authority for its CARA System, an AI-assisted retinal image analysis device detecting Diabetic Retinopathy and Age-related Macular Degeneration. This approval opens access to a large market of over 5 million adults in Saudi Arabia needing regular screening for these conditions.

This Wire brief sits within Fusion42's coverage of Digital Health, and 3 sources have reported it.

◆ ◆ The Wire takeaway

You gain a new market unlocked by Saudi FDA approval of AI retinal screening tech; start building local healthcare partnerships now to reach millions needing diabetic eye care.

◆ Coverage

3 sources · 13 Aug 2026

◆ Related on Wire

◆ Topics

Digital Healthmedical-devicesaudi-fdaai-healthtechretina-screeningdiabetic-retinopathy